Trials / Conditions / Combined Hepatocellular and Cholangiocarcinoma
Combined Hepatocellular and Cholangiocarcinoma
3 registered clinical trials studyying Combined Hepatocellular and Cholangiocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Loc NCT06855225 | Mehmet Akce | Phase 2 |
| Recruiting | Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcino NCT06849180 | Zhongda Hospital | — |
| Completed | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced NCT03230318 | Basilea Pharmaceutica | Phase 2 |